Transarterial Chemoembolization With Doxorubicineluting Microspheres: Single-Center Review Of Safety Profile

Aušra Bankauskaitė, Alvydas Česas, Algimatas Šimkaitis, Loreta Malinauskienė Abstract Background. Since 1977 when TACE was introduced for the first time it became a standard treatment for nonresectable HCC without vascular invasion or extrahepatic disease. TACE is also performed for other indications, such as colorectal metastases, cholangiocarcinoma, neuroendocrine tumors and etc. Material/methods. the evaluation of interventional…